Summerschool in Immuno-Oncology 2021

Chair: P. Verginis

10:00-10:40 Immunosurveillance, Immunoediting and Immune escape J. Wiscchusen
10:40-11:20 Cancer immune escape mechanisms N. Aptsiauri
11:20-12:00 Immune suppression in cancer P. Verginis

Chair: J. Wiscchusen

12:30-13:10 Intracellular tumor antigen processing and immune checkpoint blockade E. Stratikos
13:10-13:50 Regulation of immune checkpoint blockade clinical outcomes by Immune and cancer gene signatures D. Speiser

Chair: A. Kotsakis

16:00-16:40 Current status of immunotherapy in NSCLC D. Papadatos-Pastos
16:40-17:20 Current status of immunotherapy in SCLC and Mesothelioma K. Leventakos

Chair: A. Kotsakis

Resistance to Immune checkpoint inhibition F. Skoulidis

Chair: E. Stratikos

18:30-19:10 Inflammation and cancer: a yin - yang affair A. Igea
19:10-19:50 Tumor microenvironment in solid tumors I. Pateras
19:50-20:30 The host-microbiome crosstalk and its impact on tumorigenesis T. Frisan

Chair: D. Mastellos

10:00-10:40 Cellular therapy (CAR T-cells) G. Vassilopoulos
10:40-11:20 Natural Killers for cancer immunotherapy A. Madrigal

Chair: O. Tsitsilonis

11:50-12:30 Cancer Vaccines Κ. Kosmatopoulos
12:30-13:10 Therapeutic targeting of the complement system D. Mastellos

Chair: M. Koukourakis

15.30-16.10 Routine biomarkers in routine practice A. Giatromanolaki
16.10-16.50 Genomic Landscape of Response and Resistance to Immune Checkpoint Blockade V. Anagnοstou
16:50-17:30 HRD and immunotherapy M. Liontos

Chair: A. Giatromanolaki

17.30-18.10 The immunotherapy landscape for renal cell carcinoma F. Koinis
18.10-18.50 State of the art of immunotherapy in urothelial cancer P. Grivas
18.50-19.20 The current status of immunotherapy in GI tumors G. Papaxoinis

Chair: O. Tsitsilonis

10:00-10:40 miRNAs B. Seliger
10:40-11:20 Immune modulation for cancer treatment G. Adema
11:20-12:00 Anti-cancer immunity and aging G. Pawelec

Chair: G. Pawelec

12:30-13:10 State of the art of immunotherapy in malignant melanoma H. Gogas
13:10-13:50 Advances of immunotherapy in breast cancer D. Tryfonopoulos
13:50-14:30 The role of Cemiplimab in the management of advanced cutaneous squamous cell carcinoma I. Samaras
Sponsored By Sanofi Genzyme

Chair: Α. Kotsakis

15:30-16:10 Targeting Cancer with BiTE® Constructs R. Kischel
16:10-16:50 Emerging immunotherapy targets M. Karasarides
16:50-17:30 Therapeutic approach of immune adverse events A. Koumarianou

Adema G.
Professor, Chair in Molecular Immunology, Radiotherapy & OncoImmunology laboratory, Department of Radiation Oncology RadboudUMC, Nijmegen, The Netherlands
Anagnostou V.
MD, PhD, Assistant Professor, Medical Oncology, Director, Thoracic Oncology Biorepository, Upper Aerodigestive Oncology Program, Co-leader, Molecular Tumor Board, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, U.S.A
Aptsiauri N.
MD, PhD, Associate Professor, Department of Biochemistry, Molecular Biology III and Immunology, University of Granada Medical School, Granada, Spain
Baxevanis C.
Scientific Director, Cancer Immunology and Immunotherapy Center, Agios Savvas Hospital, Athens, Greece
Frisan T.
Professor, Department Molecular Biology, Umeå Centre for Microbial Research (UCMR), Umeå University, Sweden
Georgoulias V.
Emeritus Professor of Medical Oncology, School of Medicine, University of Crete, Heraklion, Crete, Greece
Giatromanolaki A.
MD, Professor - Head, Department of Pathology, Medical School, Democritus University of Thrace, Greece
Gogas H.
Professor of Medical Oncology, 1st Department of Medicine, Laiko Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece
Grivas P.
MD, PhD, Associate Professor, Department of Medicine, Division of Medical Oncology, Clinical Director, Genitourinary Cancers Program, University of Washington, Associate Professor, Clinical Research Division, Fred Hutchinson Cancer Research Center, USA
Igea A.
PhD, IDIS Foundation, Santiago de Compostela, Spain
Karasarides M.
PhD, Vice President, Worldwide Medical Oncology, Early Assets and Biomarkers, BMS
Kischel R.
MD, Director Research - BiTE Technology, AMGEN Research (Munich) GmbH, Germany
Koinis F.
MD, PhD, Assistant Professor of Medical Oncology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Larissa, Greece
Kosmatopoulos K.
Chief Executive Officer, Vaxon Biotech, Paris, France
Kotsakis A.
MD, PhD, Associate Professor of Medical Oncology, Director of Department of Medical Oncology, University Hospital of Larisa, Thessaly, Greece
Koukourakis M.
Radiation Oncologist, Professor, Medical School, Democritus University of Thrace - Head Dept of Radiotherapy - Oncology, Radiobiology and Radiopathology Unit, Universiy Hospital of Alexandroupolis, Greece
Koumarianou A.
MD, PhD in Tumor Immunotherapies, Imperial College, Consultant in Medical Oncology, 4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece
Leventakos K.
MD, PhD, Assistant Professor, Chest oncology and clinical studies phase 1, Mayo Clinic, Rochester, U.S.A.
Liontos M.
PhD, Medical Oncologist, Consultant, Department of Clinical Therapeutics, Alexandra Hospital, Athens, Greece
Madrigal A.
MD, PhD, FRCP, FRCPath, DSc, HonDSci, FMedSci, Professor of Haematology, UCL Cancer Institute, Honorary Consultant, Royal Free NHS Trust, UCL Country Ambassador for México
Mastellos D.
PHD, Director of Research (Researcher A), Molecular Immunology Group, Division of Biodiagnostic Sciences and Technologies, I/NRASTES, National Center for Scientific Research Demokritos, Athens, Greece
Papadatos – Pastos D.
MRCP (UK) PhD, Consultant in Medical Oncology, Lung Cancer and Acute Oncology, University College London Hospitals and The Princess Alexandra Hospital, London, UK
Papaxoinis G.
Consultant Medical Oncologist, Agios Savvas Anticancer Hospital, National and Kapodistrian University of Athens, Greece
Pateras I.
Bsc, MD, PhD, Pathologist, Assistant Professor, Department of Histology and Embryology, Medical School, National and Kapodistrian University of Athens, Greece
Pawelec G.
Professor of Experimental Immunology, Department of Immunology, University of Tübingen, Tübingen, Germany, Health Sciences North Research Institute, Sudbury, Ontario, Canada
Samaras I.
MD, Medical Oncologist, University Hospital of Larissa, Greece
Seliger B.
Professor of Immunology, Institute of Medical Immunology, Martin - Luther - University Halle - Wittenberg, Halle, Germany
Skoulidis F.
MD, PhD, Assistant Professor, Department of Thoracic and Head and Neck Medical Oncology, The University of Texas, MD Anderson Cancer Center, U.S.A.
Speiser D.
Professor, Expert Group Immunology, Swiss National COVID-19 Science Task Force, Department of Oncology, University of Lausanne, Lausanne, Switzerland
Stratikos E.
Associate Professor, Biochemistry Department of Chemistry, National and Kapodistrian University of Athens, Greece
Tryfonopoulos D.
MD, MSc, PhD, Medical Oncologist, Anti-Cancer Hospital Agios Savvas, Athens, Greece
Tsitsilonis O.
Professor in Immunology, Department of Animal and Human Physiology, Faculty of Biology, University of Athens, Greece
Vassilopoulos G.
Associate Professor of Pathology - Hematology, University of Thessaly, Director of the Hematology Clinic of University Hospital of Larisa, Collaborating Faculty Member, Genetics Laboratory & Gene Therapy (IIBEAA), Athens, Greece
Verginis P.
Associate Professor Immunology, Biochemistry, School of Medicine, University of Crete, Heraklion, Greece
Wischhusen J.
PhD, Professor of Experimental Tumor Immunology, University of Würzburg School of Medicine, Department of Gynecology and Obstetrics, Germany

Based on the latest circular of the National Drug Organization the event is required to use an attendance tracking system. Certificates are given to those who have attended at least 60% of the total hours of the Scientific Program, at the end of the scientific event. The “Evaluation Form – Certificate” link will appear at the end of the event, on event’s page and will remain active for one week. The event has been awarded by Panhellenic Medical Association (PIS) with 20 CME - CPD credits.

Click the "Sign Up" button at the top right of the page and fill in the form.

The attendance time record is displayed on the right side of the page of the event you are attending.
The attendance time counter starts after you have subscribed and once the event has started. The display of this field informs the user about the time (minutes) he has watched.

The appearance of the pop-up window serves the transparency and reliability of the data, which are finally collected after the event.

The duration of a pop-up window when watching a live event is two minutes, while the repetition of an appearance is about every sixty minutes. During this period, the participant of the event must choose one of the two conditions that appear in the pop-up window.

Otherwise, the system will stop recording the tracking time.

 

Once you have signed in with your passwords (if you don't have passwords please follow the account creation process), select the event you want to watch and press the "Subscribe to this event" button.

Τhe window where you can ask your questions, will appear next to the live streaming window.

 

To receive your certificate, it is necessary to press the "Subscribe to this event" button to the scientific event you are interested in, as well as to have attended 60% of the total hours of the scientific program (in case of medical scientific event).
You can receive your certificate through the field "DOWNLOAD YOUR CERTIFICATE" and and after you have filled in the evaluation form.
Certificates are given at the end of the scientific event.

Technical Support is available:

- everyday 09:00-17:00

- at the day of the event 09:00-21:00

For Technical Support please contact us:

Phone: +30 210 72 40 039

Email: support@livetime.gr

Event Details